At Sechenov University, a study was conducted in which scientists compared three approaches to treating anxiety disorders. The study involved 94 patients. The first group received traditional pharmacotherapy, the second practiced mindfulness with the use of biofeedback (BFB), and the third combined both methods. The results were impressive and were published in the journal «Clinical and Special Psychology». On the Hamilton scale, which measures the intensity of anxiety on a scale from 0 to 56 points, immediately after the ten-day course anxiety in the mindfulness-with-BFB group fell to 14,6 points, in the combined group — to 15,9, whereas in the medication-only group it stopped at 21,2 points. A month later the picture became even more convincing: the combined method held the result at the level of 13,4 points versus 20,1 points in the group receiving exclusively pharmacological treatment.
The key difference of the non-pharmacological approach is that the patient does not merely receive passive relief of symptoms, but actively masters a specific self-regulation skill that can be used for a lifetime. Biofeedback equipment translates in real time breathing, heart rate and the brain's electrical activity into video and audio signals — the patient literally sees and hears on the screen how his or her body is working. The director of the Institute of Psychological and Social Work at Sechenov University, Maria Kiseleva, emphasizes the main advantage: the patient receives not just relief, but a tool that can be applied independently at the slightest onset of discomfort — without a doctor, without pills, by his or her own volition alone.
Why does this work? Modern neuroscience offers several explanations. According to the theory of predictive processing, the brain constantly predicts what should happen in the body, and then compares these predictions with actual signals. In chronic anxiety this mechanism is disrupted: the brain overestimates the danger of internal signals (accelerated pulse, muscle tension, rapid breathing), creating a vicious circle of false alarms. Mindfulness practices, especially in combination with biofeedback, train interoception — the ability to accurately recognize and name one's bodily sensations. This makes it possible to reduce the influence of the brain's erroneous predictions and give the body the opportunity to recalculate its own model of danger. Pharmacological drugs simply suppress symptoms; this approach, by contrast, addresses the root of the problem — the very mechanism on which the perception of bodily signals is built.
The study has limitations that are important to acknowledge. The sample is relatively small (94 people), the programs are short (10 days), and long-term observation is limited to one month. Some details of the methodology — the degree of blinding of the control and the randomization procedure — are not fully disclosed in the publication. However, the statistical gap between the groups is noticeable and stable precisely where the key factor becomes an active skill rather than the passive administration of a drug. This picture is consistent with a growing scientific base: studies and meta-analyses demonstrate that mindfulness practice reduces anxiety symptoms and its effectiveness is comparable to cognitive-behavioral therapy, while the addition of biofeedback enhances the result thanks to concrete, visible feedback.
Imagine a person learning to walk on a tightrope. A pill can temporarily remove the trembling in the knees, but only systematic training with immediate feedback from the vestibular apparatus forms a stable skill. Exactly the same happens with anxiety: mindfulness and biofeedback give the patient direct access to his or her own physiological signals in real time. Anxiety ceases to be a menacing, uncontrollable state and becomes a manageable, predictable process. A person sees on the screen how his or her own breathing slows the pulse, and feels relief — not because the body has been suppressed by medication, but because he or she has learned to regulate himself or herself.
If the results are confirmed in larger multicenter studies with long-term observation, this could fundamentally reshape clinical practice. Today pharmacotherapy often remains the first line of defense. Tomorrow the question may be posed differently: it will concern not only what relieves acute symptoms faster and more effectively, but also which approach grants a person a more accurate, deeper and longer-term model of his or her own body and mind — a model on which he or she can rely for a lifetime, regardless of circumstances.
